Institutional
General Catalyst Group Management, LLC
CIK 0001637946
$183.6M
Reported AUM
12
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · General Catalyst Group Management, LLC · Q1 2026
AI · grounded in 13F
General Catalyst Group Management, LLC established a new position in EIKN valued at $3.2M. The fund also added five new positions to its portfolio, including LIFE at $828,579 and CPNG at $692,462. Other new entries include AMZN and META. The fund reduced no existing positions during the period.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IOT | SAMSARA INC | $35.80 | -7.61% | -0.58% | 97.79% | $63.4M | 34.53% | — | HELD |
| 2 | AVBP | ARRIVENT BIOPHARMA INC | $30.66 | 2.06% | 64.31% | 42.34% | $34.5M | 18.79% | — | HELD |
| 3 | MAZE | MAZE THERAPEUTICS INC | $27.63 | 1.32% | 85.44% | 125.92% | $30.9M | 16.85% | — | HELD |
| 4 | CART | MAPLEBEAR INC | $44.75 | -1.95% | -2.91% | 85.30% | $26.6M | 14.50% | — | HELD |
| 5 | GTLB | GITLAB INC | $33.72 | -0.91% | -23.31% | -66.78% | $19.9M | 10.86% | — | HELD |
| 6 | EIKN | EIKON THERAPEUTICS INC | $9.62 | 6.77% | -33.66% | -9.07% | $3.2M | 1.76% | — | HELD |
| 7 | GUTS | FRACTYL HEALTH INC | $0.69 | 0.00% | -61.88% | -90.68% | $2.2M | 1.22% | — | HELD |
| 8 | LIFE | ETHOS TECHNOLOGIES INC | $20.27 | 2.17% | 34.68% | 64.13% | $829K | 0.45% | — | HELD |
| 9 | CPNG | COUPANG INC | $16.09 | 6.13% | -44.02% | -46.30% | $692K | 0.38% | — | HELD |
| 10 | AMZN | AMAZON COM INC | $235.50 | 3.90% | 9.66% | 35.70% | $538K | 0.29% | — | HELD |
| 11 | META | META PLATFORMS INC | $539.03 | -7.95% | -21.66% | 55.72% | $376K | 0.21% | — | HELD |
| 12 | FIG | FIGMA INC | $23.76 | -4.04% | -80.52% | -66.19% | $314K | 0.17% | — | HELD |
Source: SEC EDGAR · accession 0000905148-26-002373. 13F discloses long positions only — shorts, foreign equities, and options are excluded.